STOCK TITAN

Adapthealth Corp Stock Price, News & Analysis

AHCO Nasdaq

Welcome to our dedicated page for Adapthealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on Adapthealth stock.

AdaptHealth Corp (NASDAQ: AHCO) operates as one of the largest home medical equipment and respiratory services providers in the United States, with operations spanning 46 states. As a publicly traded healthcare company, AdaptHealth regularly generates news across several categories that matter to investors and healthcare industry observers tracking the home medical equipment sector.

Earnings announcements represent a significant portion of AdaptHealth news coverage, with quarterly and annual results providing insight into revenue trends across the company's therapeutic segments including sleep therapy, respiratory equipment, mobility products, and wound care supplies. These financial disclosures reveal how the company navigates Medicare reimbursement rates, payor mix changes, and demand patterns for home healthcare equipment.

Partnership and acquisition news frequently emerges from AdaptHealth as the company has built its national presence through strategic growth. Announcements involving health system partnerships, regional acquisitions, or expanded service agreements signal how the company is extending its geographic reach and referral networks. These developments matter because scale provides competitive advantages in an industry with pressure on reimbursement rates.

Investor conference participation and analyst presentations offer windows into management perspectives on industry trends, including the ongoing shift toward home-based care delivery, chronic disease management outside hospitals, and the impact of healthcare policy on durable medical equipment providers. Credit rating changes and debt refinancing activities also generate news given the capital-intensive nature of equipment distribution.

Bookmark this page to follow AdaptHealth developments including earnings releases, strategic transactions, and operational updates relevant to understanding this home healthcare equipment company's trajectory.

Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO), a top provider of home medical equipment in the U.S., announced that its Co-CEOs, Luke McGee and Steve Griggs, along with CFO Jason Clemens, will present at two upcoming investor conferences.

  • SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 3:00 p.m. ET.
  • J.P. Morgan Global High Yield & Leveraged Finance Conference on March 3, 2021, at 11:30 a.m. ET.

Live webcasts will be available on AdaptHealth’s website. The company serves nearly 3 million patients annually through a network of over 500 locations across 46 states.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.93%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) will announce its financial results for Q4 and full year 2020 on March 4, 2021, before market opening. A conference call is scheduled for 8:30 am ET that same day to discuss the results and business activities. Interested parties can join by calling either (877) 423-9820 (Domestic) or (201) 493-6749 (International). After the call, a replay will be available on the Company’s website for six months under 'Investor Relations.'

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
conferences earnings
-
Rhea-AI Summary

AeroCare Holdings has been acquired by AdaptHealth Corp. in a deal valued at approximately $1.1 billion in cash and 31 million shares of stock. This acquisition allows AeroCare’s shareholders, including management and private investors, to become shareholders of AdaptHealth. AeroCare provides home medical equipment and services to over 1 million patients annually, showcasing 20 years of consecutive revenue growth. The merger is anticipated to enhance operational efficiencies and market leadership in the healthcare sector, addressing the needs of chronically ill patients.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.46%
Tags
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has completed its acquisition of AeroCare Holdings Inc. for approximately $1.1 billion in cash and stock, enhancing its home healthcare services. The deal includes 31 million shares of AdaptHealth common stock, subject to shareholder approval. This acquisition enables AdaptHealth to reach nearly 3 million patients across 46 states through over 500 locations. The company will be co-led by AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs while expanding its Board of Directors. The transaction was funded through senior notes and credit facility adjustments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.46%
Tags
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 10:00 am EST. The conference runs from January 11-14, 2021, and will be conducted virtually. Interested parties can access a live webcast and replay via the Investors section on www.adapthealth.com. AdaptHealth is a prominent provider of home medical equipment and services, catering to over 1.8 million patients annually across the U.S. through its network of 269 locations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
conferences
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has priced its public offering of 8,000,000 shares of Class A Common Stock at $33.00 per share, aiming for gross proceeds of approximately $239.25 million. The offering includes 7,250,000 shares from the Company and 750,000 from a selling stockholder, with a 30-day option for underwriters to purchase an additional 1,200,000 shares. Proceeds will fund the acquisition of AeroCare Holdings, Inc. and general corporate purposes. The offering is set to close on January 8, 2021, pending customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.87%
Tags
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has initiated a public offering of 7,000,000 shares of its Class A Common Stock, with an additional 1,000,000 shares offered by certain selling stockholders. The offering may also include a 30-day option for underwriters to purchase up to 1,200,000 additional shares. Proceeds will primarily finance the acquisition of AeroCare Holdings, with the remainder allocated for general corporate purposes. The company will not gain any proceeds from shares sold by selling stockholders, and the offering's completion is independent of the AeroCare acquisition.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.34%
Tags
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has priced a $500 million offering of 4.625% senior notes due 2029. Proceeds will fund the acquisition of AeroCare Holdings, with completion expected in Q1 2021, pending customary conditions. If the acquisition isn’t finalized by May 31, 2021, the notes will be redeemed at 100% of their principal. The offering is exclusively for qualified institutional buyers and has not been registered under the Securities Act. AdaptHealth serves approximately 1.8 million patients across 41 states, providing essential home healthcare equipment and services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.57%
Tags
none
-
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has initiated an offering of $500 million senior notes due 2029 through its subsidiary, AdaptHealth LLC. The proceeds will be held in escrow until the completion of the acquisition of AeroCare Holdings, Inc. The acquisition is projected to close in Q1 2021, with potential redemption of the notes if not completed by May 31, 2021. The notes will be guaranteed by various subsidiaries, and are offered exclusively to qualified institutional buyers. This press release does not constitute an offer to sell securities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
none
Rhea-AI Summary

AdaptHealth Corp. (NASDAQ: AHCO) has announced its decision to acquire AeroCare Holdings, Inc. for approximately $2.0 billion. The deal includes $1.1 billion in cash and 31 million shares of AdaptHealth common stock. This merger is expected to enhance AdaptHealth's geographic presence, reaching 47 out of 48 continental US states and solidifying partnerships with healthcare providers. The company also raised its 2021 financial guidance significantly, projecting net revenues of $2.05 billion to $2.20 billion and Adjusted EBITDA of $480 million to $515 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.79%
Tags

FAQ

What is the current stock price of Adapthealth (AHCO)?

The current stock price of Adapthealth (AHCO) is $9.96 as of December 31, 2025.

What is the market cap of Adapthealth (AHCO)?

The market cap of Adapthealth (AHCO) is approximately 1.4B.
Adapthealth Corp

Nasdaq:AHCO

AHCO Rankings

AHCO Stock Data

1.37B
110.66M
8.14%
105.09%
7.72%
Medical Devices
Services-home Health Care Services
Link
United States
CONSHOHOCKEN